HT-29 and Caco-2 reporter cell lines for functional studies of nuclear factor kappa B activation

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Mastropietro, Giuliana ^a   Tiscornia, Inés ^a   Perelmuter, Karen ^a   Astrada, Soledad ^a   Bollati Fogolín, Mariela ^a  

^a INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOPEPTIDE; GENTAMICIN; HYGROMYCIN B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TRANSCRIPTION FACTOR RELA;

APICAL MEMBRANE; ARTICLE; CACO 2 CELL LINE; CELL STIMULATION; CELL VIABILITY; COCULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HT 29 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LACTIC ACID BACTERIUM; PRIORITY JOURNAL; REPORTER GENE; CACO-2 CELL LINE; CELL POLARITY; FLUORESCENT ANTIBODY TECHNIQUE; HT-29 CELL LINE; PHYSIOLOGY;

BACTERIA (MICROORGANISMS);

CACO-2 CELLS; CELL POLARITY; FLUORESCENT ANTIBODY TECHNIQUE; HT29 CELLS; HUMANS; NF-KAPPA B; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

EID: 84925652345     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/860534     Document Type: Article

References (23)

1. A. Nenci, C. Becker, A. Wullaert et al., "Epithelial NEMO links innate immunity to chronic intestinal inflammation," Nature, vol. 446, no. 7135, pp. 557-561, 2007.
2. L. W. Peterson and D. Artis, "Intestinal epithelial cells: regulators of barrier function and immune homeostasis," Nature Reviews Immunology, vol. 14, no. 3, pp. 141-153, 2014.
3. V. Tergaonkar, "NFkappaB pathway: a good signaling paradigm and therapeutic target," The International Journal of Biochemistry and Cell Biology, vol. 38, no. 10, pp. 1647-1653, 2006.
4. A. S. Baldwin, "Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB," The Journal of Clinical Investigation, vol. 107, no. 3, pp. 241-246, 2001.
5. A. S. Baldwin Jr., "The NF-kappa B and I kappaB proteins: new discoveries and insights," Annual Review of Immunology, vol. 14, pp. 649-681, 1996.
6. O. J. Trask, "Nuclear factor kappa B (NF-kappaB) translocation assay development and validation for high content screening," in Assay Guidance Manual, G. S. Sittampalam, N. Gal-Edd, M. Arkin et al., Eds., National Center for Advancing Translational Sciences, Bethesda, Md, USA, 2004.
7. O. Maguire, C. Collins, K. O'Loughlin, J. Miecznikowski, and H. Minderman, "Quantifying nuclear p65 as a parameter for NF-κB activation: correlation between ImageStreamcytometry, microscopy, and Western blot," Cytometry Part A, vol. 79, no. 6, pp. 461-469, 2011.
8. O. Lakhdari, A. Cultrone, J. Tap et al., "Functional metagenomics: a high throughput screening method to decipher microbiota- driven NF-kappaB modulation in the human gut," PLoS ONE, vol. 5, no. 9, Article ID e13092, 2010.
9. C. E. Badr, J. M. Niers, L.-A. Tjon-Kon-fat, D. P. Noske, T. Wurdinger, and B. A. Tannous, "Real-time monitoring of Nuclear factor kappaB activity in cultured cells and in animal models," Molecular Imaging, vol. 8, no. 5, pp. 278-290, 2009.
10. M. Mohamadzadeh, S. Olson, W. V. Kalina et al., "Lactobacilli active human dendritic cells that skew T cells toward T helper 1 polarization," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 8, pp. 2880-2885, 2005.
11. L. van Overtvelt, V. Lombardi, A. Razafindratsita et al., "IL- 10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model," International Archives of Allergy and Immunology, vol. 145, no. 2, pp. 152-162, 2008.
12. M. Z. Köster, J. Pulverer, F. Sasse, and H. Hauser, "System for the determination of molecules altering the function of interferon, method therefor and compounds altering interferon activity," in Helmholtz-Zentrum für Infektionsforschung GmbH, 2009.
13. A. T. Gewirtz, K. A. Reed, D. Merlin, M. Hobert, A. S. Neish, and J. L. Madara, "21modeling microbial-epithelial interactions in the intestine," Methods in Microbiology, vol. 31, pp. 377-396, 2002.
14. J.-C. Bambou, A. Giraud, S. Menard et al., "In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain," The Journal of Biological Chemistry, vol. 279, no. 41, pp. 42984-42992, 2004.
15. A.M. O'Hara, P. O'Regan, Á. Fanning et al., "Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius," Immunology, vol. 118, no. 2, pp. 202-215, 2006.
16. M. Cammarota, M. de Rosa, A. Stellavato, M. Lamberti, I. Marzaioli, and M. Giuliano, "In vitro evaluation of Lactobacillus plantarum DSMZ 12028 as a probiotic: emphasis on innate immunity," International Journal of Food Microbiology, vol. 135, no. 2, pp. 90-98, 2009.
17. G. Zhang, V. Gurtu, and S. R. Kain, "An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells," Biochemical and Biophysical Research Communications, vol. 227, no. 3, pp. 707-711, 1996.
18. I. Treede, A. Braun, P. Jeliaskova et al., "TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells," BMC Gastroenterology, vol. 9, article 53, 2009.
19. S. Vallee, S. Laforest, F. Fouchier, M. P. Montero, C. Penel, and S. Champion, "Cytokine-induced upregulation of NF-kappaB, IL- 8, and ICAM-1 is dependent on colonic cell polarity: implication for PKCdelta," Experimental Cell Research, vol. 297, no. 1, pp. 165-185, 2004.
20. E. P. Molmenti, T. Ziambaras, and D.H. Perlmutter, "Evidence for an acute phase response in human intestinal epithelial cells," The Journal of Biological Chemistry, vol. 268, no. 19, pp. 14116-14124, 1993.
21. G.W. Varilek, G. A. Neil, and W. P. Bishop, "Caco-2 cells express type I interleukin-1 receptors: ligand binding enhances proliferation," The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 267, no. 6, part 1, pp. G1101-G1107, 1994.
22. A. T. Borchers, C. Selmi, F. J. Meyers, C. L. Keen, and M. E. Gershwin, "Probiotics and immunity," Journal of Gastroenterology, vol. 44, no. 1, pp. 26-46, 2009.
23. S. E. Jones and J. Versalovic, "Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors," BMC Microbiology, vol. 9, article 35, 2009.